Galapagos

Galapagos starts timer on AbbVie buy-in decision with posting of final data
Fierce Biotech
Fri, 08/14/15 - 09:20 am
Galapagos
AbbVie
JAK inhibitors
rheumatoid arthritis
filgotinib
Galapagos peaks as AbbVie hype builds, Shorts target Bavarian, MorphoSys makes GPCR play
Fierce Biotech
Fri, 08/7/15 - 10:44 am
Galapagos
AbbVie
Bavarian Nordic
Intec Pharma
MorphoSys
Galapagos leases one-third of Sanofi-founded biopark to consolidate French R&D operations
Fierce Biotech
Fri, 06/5/15 - 09:22 am
R&D
Galapagos
Sanofi
France
Galapagos Receives a Rousing Welcome on Its First Day of Trading
TheStreet.com
Fri, 05/15/15 - 09:25 am
Galapagos
Galapagos inflates IPO again as AbbVie, J&J jockey for position
Fierce Biotech
Thu, 05/14/15 - 11:02 am
Galapagos
IPOs
AbbVie
JNJ
AbbVie: The Old & the New
Barron's
Wed, 04/15/15 - 08:55 am
AbbVie
Galapagos
Humira
Galapagos loses partner on inflammatory bowel drug
Yahoo/Reuters
Tue, 12/16/14 - 07:59 am
Galapagos
inflammatory bowel disease
Janssen
ulcerative colitis
GLPG1205
Biotech firm Galapagos says GSK stops joint drug project
Yahoo/Reuters
Fri, 08/8/14 - 08:36 am
GSK
Galapagos
GSK2586184
ulcerative colitis
GlaxoSmithKline hits the brakes on an anti-inflammatory drug from Galapagos
Fierce Biotech
Mon, 03/3/14 - 10:31 am
GSK
Galapagos
GSK2586184
lupus
Galapagos sees cystic fibrosis clinical trials in 2014
Yahoo/Reuters
Thu, 10/17/13 - 08:22 am
cystic fibrosis
Galapagos
Why AbbVie's Global Alliance With Galapagos Is Good News for Investors
Motley Fool
Fri, 10/4/13 - 11:15 am
AbbVie
Galapagos
cystic fibrosis
Successor To Humira? AbbVie And Galapagos Work On It
Seeking Alpha
Tue, 06/18/13 - 08:54 am
Humira
AbbVie
Galapagos
GLPG0634
Chron's Disease
Incyte
Eli Lilly
Pfizer
rheumatoid arthritis
[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool
Tue, 05/21/13 - 10:06 am
AbbVie
Crohn's Disease
JAK inhibitors
Galapagos
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Yahoo/Reuters
Fri, 05/17/13 - 10:43 am
Galapagos
AbbVie
GLPG0634
Crohn's Disease
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:47 pm
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Galapagos looking for acquisitions after drug deal
Reuters
Wed, 02/29/12 - 11:02 am
Abbott Laboratories
M&A
Galapagos
Galapagos inks $367M deal in back-ended discovery pact with Servier
Fierce Biotech
Mon, 10/3/11 - 11:46 am
Servier
Galapagos
Galapagos gains third extension of Genentech deal in $35M pact
Fierce Biotech
Thu, 08/18/11 - 02:17 pm
Genentech
Galapagos
Argenta
Galapagos, Merck Agree to End Strategic Alliances
Bloomberg
Fri, 02/4/11 - 11:04 am
Merck
Galapagos
Galapagos updates progress in GSK arthritis trials
Marketwatch
Tue, 01/11/11 - 12:28 pm
GSK
Galapagos
arthritis

Pages